|
1
|
Angulo P and Lindor KD: Non-alcoholic
fatty liver disease. J Gastroenterol Hepatol. 17(Suppl): S186–S190.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Başaranoğlu M and Örmeci N: Nonalcoholic
fatty liver disease: diagnosis, pathogenesis, and management. Turk
J Gastroenterol. 25:127–132. 2014. View Article : Google Scholar
|
|
3
|
Du J, Ma YY, Yu CH and Li YM: Effects of
pentoxifylline on nonalcoholic fatty liver disease: a
meta-analysis. World J Gastroenterol. 20:569–577. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duvnjak M, Lerotić I, Barsić N, Tomasić V,
Virović Jukić L and Velagić V: Pathogenesis and management issues
for non-alcoholic fatty liver disease. World J Gastroenterol.
13:4539–4550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi Y, Sugimoto K, Inui H and
Fukusato T: Current pharmacological therapies for nonalcoholic
fatty liver disease/nonalcoholic steatohepatitis. World J
Gastroenterol. 21:3777–3785. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Papandreou D and Andreou E: Role of diet
on non-alcoholic fatty liver disease: an updated narrative review.
World J Hepatol. 7:575–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Puri P, Mirshahi F, Cheung O, Natarajan R,
Maher JW, Kellum JM and Sanyal AJ: Activation and dysregulation of
the unfolded protein response in nonalcoholic fatty liver disease.
Gastroenterology. 134:568–576. 2008. View Article : Google Scholar
|
|
8
|
Zhang K and Kaufman RJ: The unfolded
protein response: a stress signaling pathway critical for health
and disease. Neurology. 66(Suppl 1): S102–S109. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SR, Kim DI, Kang MR, Lee KS, Park SY,
Jeong JS and Lee YC: Endoplasmic reticulum stress influences
bronchial asthma pathogenesis by modulating nuclear factor κB
activation. J Allergy Clin Immunol. 132:1397–1408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ayala P, Montenegro J, Vivar R, Letelier
A, Urroz PA, Copaja M, Pivet D, Humeres C, Troncoso R, Vicencio JM,
et al: Attenuation of endoplasmic reticulum stress using the
chemical chaperone 4-phenylbutyric acid prevents cardiac fibrosis
induced by isoproterenol. Exp Mol Pathol. 92:97–104. 2012.
View Article : Google Scholar
|
|
11
|
Hotamisligil GS: Endoplasmic reticulum
stress and the inflammatory basis of metabolic disease. Cell.
140:900–917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cai D, Yuan M, Frantz DF, Melendez PA,
Hansen L, Lee J and Shoelson SE: Local and systemic insulin
resistance resulting from hepatic activation of IKK-beta and
NF-kappaB. Nat Med. 11:183–190. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N and Karin M: Signaling pathways
leading to nuclear factor-kappa B activation. Methods Enzymol.
319:273–279. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bao QD, Yang LL and Wang L: Protective
effects of magnesium isoglycyrrhizinate against carbon
tetrachloride-induced acute liver injury in mice. World Chin J
Digestology. 16:1004–1007. 2008.
|
|
15
|
Dong LP, Yu F, Liu J and Mu XM: Protective
effect of magnesium isoglycyrrhizinate on acute hepatic injury in
mice. China Pharmacy. 17:902–904. 2006.
|
|
16
|
Mao YM, Zeng MD, Chen Y, Chen CW, Fu QC,
Cai X, Wu SM, Chen YG, Sun Y, Li J, et al: Magnesium
isoglycyrrhizinate in the treatment of chronic liver diseases: a
randomized, double-blind, multi-doses, active drug controlled,
multi-center study. Zhonghua Gan Zang Bing Za Zhi. 17:847–851.
2009.In Chinese. PubMed/NCBI
|
|
17
|
Cheng Y, Zhang J, Shang J and Zhang L:
Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2
cells by magnesium isoglycyrrhizinate in vitro. Pharmacology.
84:183–190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao ZW, Zhang W, Ma L and Qiu ZW:
Therapeutic effect of magnesium isoglycyrrhizinate in rats on lung
injury induced by paraquat poisoning. Eur Rev Med Pharmacol Sci.
18:311–320. 2014.PubMed/NCBI
|
|
19
|
Chen KJ, Chen WY, Chen X, Jia YM, Peng GQ
and Chen L: Increased elimination of paclitaxel by magnesium
isoglycyrrhizinate in epithelial ovarian cancer patients treated
with paclitaxel plus cisplatin: a pilot clinical study. Eur J Drug
Metab Pharmacokinet. 39:25–31. 2014. View Article : Google Scholar
|
|
20
|
Abe K, Ikeda T, Wake K, Sato T, Sato T and
Inoue H: Glycyrrhizin prevents of
lipopolysaccharide/D-galactosamine-induced liver injury through
down-regulation of matrix metalloproteinase-9 in mice. J Pharm
Pharmacol. 60:91–97. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ziamajidi N, Khaghani S, Hassanzadeh G,
Vardasbi S, Ahmadian S, Nowrouzi A, Ghaffari SM and Abdirad A:
Amelioration by chicory seed extract of diabetes- and oleic
acid-induced non-alcoholic fatty liver disease
(NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of
PPARα and SREBP-1. Food Chem Toxicol. 58:198–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Alkhatatbeh MJ, Lincz LF and Thorne RF:
Low simvastatin concentrations reduce oleic acid-induced steatosis
in HepG2 cells: An in vitro model of non-alcoholic fatty liver
disease. Exp Ther Med. 11:1487–1492. 2016.PubMed/NCBI
|
|
23
|
Malhi H, Bronk SF, Werneburg NW and Gores
GJ: Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis.
J Biol Chem. 281:12093–12101. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Henkel A and Green RM: The unfolded
protein response in fatty liver disease. Semin Liver Dis.
33:321–329. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Marciniak SJ, Yun CY, Oyadomari S, Novoa
I, Zhang Y, Jungreis R, Nagata K, Harding HP and Ron D: CHOP
induces death by promoting protein synthesis and oxidation in the
stressed endoplasmic reticulum. Genes Dev. 18:3066–3077. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshida H, Matsui T, Yamamoto A, Okada T
and Mori K: XBP1 mRNA is induced by ATF6 and spliced by IRE1 in
response to ER stress to produce a highly active transcription
factor. Cell. 107:881–891. 2001. View Article : Google Scholar
|
|
27
|
Adachi Y, Yamamoto K, Okada T, Yoshida H,
Harada A and Mori K: ATF6 is a transcription factor specializing in
the regulation of quality control proteins in the endoplasmic
reticulum. Cell Struct Funct. 33:75–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao J, Dai DL, Yao L, Yu HH, Ning B, Zhang
Q, Chen J, Cheng WH, Shen W and Yang ZX: Saturated fatty acid
induction of endoplasmic reticulum stress and apoptosis in human
liver cells via the PERK/ATF4/CHOP signaling pathway. Mol Cell
Biochem. 364:115–129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng J, Lu PD, Zhang Y, Scheuner D,
Kaufman RJ, Sonenberg N, Harding HP and Ron D: Translational
repression mediates activation of nuclear factor kappa B by
phosphorylated translation initiation factor 2. Mol Cell Biol.
24:10161–10168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu P, Han Z, Couvillon AD, Kaufman RJ and
Exton JH: Autocrine tumor necrosis factor alpha links endoplasmic
reticulum stress to the membrane death receptor pathway through
IRE1alpha-mediated NF-kappaB activation and down-regulation of
TRAF2 expression. Mol Cell Biol. 26:3071–3084. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Urano F, Wang X, Bertolotti A, Zhang Y,
Chung P, Harding HP and Ron D: Coupling of stress in the ER to
activation of JNK protein kinases by transmembrane protein kinase
IRE1. Science. 287:664–666. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nerstedt A, Cansby E, Amrutkar M, Smith U
and Mahlapuu M: Pharmacological activation of AMPK suppresses
inflammatory response evoked by IL-6 signalling in mouse liver and
in human hepatocytes. Mol Cell Endocrinol. 375:68–78. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dooley S and ten Dijke P: TGF-β in
progression of liver disease. Cell Tissue Res. 347:245–256. 2012.
View Article : Google Scholar
|
|
34
|
Yang L, Roh YS, Song J, Zhang B, Liu C,
Loomba R and Seki E: TGF-β signaling in hepatocytes participates in
steatohepatitis through regulation of cell death and lipid
metabolism. Hepatology. 59:483–495. 2014. View Article : Google Scholar
|
|
35
|
Henderson NC and Iredale JP: Liver
fibrosis: cellular mechanisms of progression and resolution. Clin
Sci (Lond). 112:265–280. 2007. View Article : Google Scholar
|
|
36
|
Marchesini G, Brizi M, Morselli-Labate AM,
Bianchi G, Bugianesi E, McCullough AJ, Forlani G and Melchionda N:
Association of nonalcoholic fatty liver disease with insulin
resistance. Am J Med. 107:450–455. 1999. View Article : Google Scholar : PubMed/NCBI
|
